Modulation of survivin expression

Details for Australian Patent Application No. 2004253455 (hide)

Owner Eli Lilly and Company Isis Pharmaceuticals, Inc.

Inventors Patel, Bharvin Kumar; Bhat, Balkrishen; Swayze, Eric

Agent Spruson & Ferguson

Pub. Number AU-B-2004253455

PCT Pub. Number WO2005/002507

Priority 60/475,324 03.06.03 US; 10/618,553 11.07.03 US; 10/823,448 13.04.04 US

Filing date 3 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 3 March 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

8 December 2005 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Patet, Bharvin Kumar to Patel, Bharvin Kumar 2005

8 December 2005 PCT application entered the National Phase

  PCT publication WO2005/002507 Priority application(s): WO2005/002507

3 March 2011 Application Accepted

  Published as AU-B-2004253455

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253460-Method for treating alcoholic hepatitis

2004253447-Asymmetric benzimidazoles and related compounds as potassium channel modulators